so it is not 'modest'....estimates will start coming down Monday for next 2-3 qtrs.
I really don't imagine there will be a line to buy a $80,000 car. I see a couple of model S on the road in California, but otside CA there are very very few electic cars. This is not an apple product, that sells for $200-$400. Stock is way overvalued.
This is not good news for TSLA stockholders..maybe good news for existing TSLA owners.
HIFU is definitely taking off in Canada, Europe, Asia. Go read their last qtr statement.
Stock price already factored in US FDA loss (but it may still get it. FDA does not need to agree with panel). Stock is undervalued now and will rise with earnings.
this is NOT going bankcrupt. It has market cap LOWER than its FY14 revenue. Europe/Asia/Canada still very big on this. Time to buy is NOW after this massive selloff.
agree...I somehow feel if this was a US company it would have got it. Their CEO even shifted operations to US to prepare for the post approval work. Its just bizzare that something that is approved in Europe for so long, that got reimbursement in France got rejected ALL votes in the panel.
stock will rally tomorrow. AH volume was only 150k...tomorrow total volume will exceed 3 mil.
this stock is a yoyo....thank Yellen for the cheap shares.
think there is going to be some profit taking next few days on EDAP. Not chasing here...
I don't think so...market cap is already at $148M (its not $130M as shown in yahoo finance). July 30th is just panel recommendation, and stock is already up from mid 3s due to July 30th event.
I agree once FDA approval does come, it may go up to $7-8. But that would be Q4FY14...who knows with FDA.
July 30th is NOT FDA approval. Plus FDA does not need to follow the recommendation either. Look it up.
given the run up....think stock will consolidate a bit since potential FDA approval is still couple of months away.
they showed very positive results from their initial trial in 2010, and said they planned to start phase II in 2011. They should have some information to share on Phase II very soon IMO.
Also, HIFU has been successfully treated for liver cancer in India...I can't paste the link, but you can search for it on the web.
Here are all the details about the upcoming July 30th panel meeting...
HAHAHAHA !! You crack me up ! Price 'may' go up if they get FDA approval ! Dude if they get FDA approval stock will go up 200% easy ! When is the last time you saw a biotech/device company not go up after FDA ???
FDA does not care about EU ? Really ?? They why all of a sudden acceleration of reviews/dates since EU recommendation in March ? Check my last post. Check theflyonthewall comments by CEO.
Also EDAP already proved to investors...HIFU revenue up 130% last qtr, profit instead of loss, big backlog, France reimbursement, EU recommendation, which is followed by all of Europe and Asia.
EDAP submitted application Feb 2013...but since they got EU primary recommendation on April 24th, looks like FDA is accelarting approval with panel recommendation date given on May 22nd (for July 30th), site visits in June, other reviews in July.
Looks like US FDA was waiting for EU to give their clearance, and how they are moving quickly as they feel much for comfortable.
Expect stock to be at $6 by July 30th, expecting a postive recommendation (they have 15 years of clinical data !! Plus Europe, Canada and Asia are using it already), and FDA approval Aug/Sept latest. Stock will go up to $20 again just like EU approval.
Buy on dips.
Just some minor consolidation and profit taking after run up last 2-3 days. Like I said will see $6 before July 31st.
Nothing goes up in a straight line. There are always short team jittery traders along the way.
this is just the start of Focal One robotic use for HIFU prostate. Expect sales to ramp up in Q2/Q3.
Also, out of the patients that were given this treatement in Germany, 3 were from US ! Looks like US is waiting to get HIFU and Focal One FDA approval.